Lipocine Inc (LPCN)

1.59 +0.01  +0.63% NASDAQ Nov 24, 20:00 USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
03/12/2021 Earnings Lipocine Inc Fourth Quarter Earnings Results for 2020
11/10/2020 Earnings Lipocine Inc Third Quarter Earnings Results for 2020
08/06/2020 Earnings Lipocine Inc Second Quarter Earnings Results for 2020
06/10/2020 10:00 MDT Misc Lipocine Inc Annual General Meeting for 2019
05/07/2020 Earnings Lipocine Inc First Quarter Earnings Results for 2020
03/13/2020 Earnings Lipocine Inc Fourth Quarter Earnings Results for 2019
03/13/2020 Misc Lipocine Inc Annual Report for 2019
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.lipocine.com
  • Investor Relations URL: http://ir.lipocine.com/index.cfm
  • HQ State/Province: Utah
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Blend
  • Next Earnings Release: Mar. 12, 2021
  • Last Earnings Release: Nov. 10, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO, is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148 and LPCN 1107.

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.